combination therapy with glp-1 receptor agonist and sglt2 inhibitor A retrospective analysis of agonists inhibitors versus SGLT2 monotherapy in patients with MASLD Frontiers | The Efficacy and
Description
A summary of all the CV events occurring during these trials are presented in Additional file 1: Table S1
Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on -cell function in Asian and Caucasian type 2 diabetes mellitus patients: a meta-analysis
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
HA, Hyperandrogenemia
P., Trujillo, J
A key limitation of this review is the absence of a formal risk of bias or quality grading tool, which is typically not required for narrative reviews
